Blueprint for Innovative Healthcare Access
Blueprint for Innovative Healthcare Access
Overview
Non-communicable diseases (NCDs) are the leading cause of death worldwide and disproportionately impact people in low- and middle-income countries. Between the physical ramifications of diagnosis to the financial burdens that come with long-term treatment, receiving the support they need throughout the entire patient journey is crucial for those living with NCDs.
The Blueprint for Innovative Healthcare Access program—a consortium led by Amref—expanded access to care and improved quality of life for people with NCDs in Kenya. Working with several community partners, the program took an integrated approach to address local health system needs and ensure a sustainable impact.
The Blueprint program enhanced care for NCDs by:
- Strengthening the capabilities and capacity of existing health systems
- Building an effective and reliable NCD supply chain management system
- Improving the allocation and use of NCD commodities, such as health products, medicines, and medical devices
- Advocating for increased NCD funding
As a consortium partner, MSH supported Meru and Makueni Counties to strengthen capacity for commodity stewardship for NCDs. Accomplishments included:
- Developed an NCD health products and technologies tracer list tool, which was integrated into the national reporting system, to improve commodity accountability and transparency
- Strengthened health system capacity and management through health worker trainings on commodity management and provision of job aids for treating NCDs
- Improved disease surveillance and research through the establishment of cancer registries
- Enhanced accessibility and utilization of NCD health services through community awareness efforts
Improving Health Supply Chains for Patients with Non-Communicable Diseases: Insights from Kenya
In this Q&A, MSH staffers Joseph Mukoko and Evelyne Kahare discuss how the Blueprint program is addressing NCDs and highlight accomplishments and lessons learned from the project in Meru County.
Joseph Mukoko
Project Lead
Project Contact
Joseph Mukoko was the project lead for the Blueprint for Innovative Healthcare Access program, funded by Takeda through AMREF, in Kenya. He has more than 23 years of experience in the public and private health sectors in Kenya, with 19 years focused on health systems strengthening at MSH. At MSH, he has held senior positions overseeing work plan activities and public health program-related interventions. As the project lead for the Blueprint for Innovative Health Access program, Mukoko focused on strengthening the pharmaceutical and supply chain systems for noncommunicable diseases in Kenya. He has also provided technical guidance and support as the principal technical advisor for the USAID Medicines, Technologies, and Pharmaceutical Services Program to address antimicrobial resistance in Kenya. Mukoko has led and supported initiatives for public health programs, including TB, malaria, HIV, and family planning, and managed technical teams to strengthen pharmaceutical and laboratory systems. Prior to joining MSH, he worked for the Ministry of Health Pharmacy and Poisons Board in the Drug Registration department. Mukoko is a registered pharmacist in Kenya with a bachelors in pharmacy from the University of Nairobi and a postgraduate diploma in epidemiology from the University of London.
Donors & Partners
Donors
Takeda Pharmaceuticals
Partners
Amref Health Africa
Elewa Cancer Foundation
International Cancer Institute
Kenya Medical Research Institute (KEMRI)
Kenya Hospices and Palliative Care Association (KEHPCA)
Non-Communicable Diseases Alliance Kenya (NCDAK)
Innovations in Healthcare (IiH)